Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions

HealthyOsteopeniaOsteoporosis Risk

Interventions

DRUG

Everolimus

Everolimus 5 mg administered once weekly for 24 weeks

DRUG

Placebo

Placebo administered once weekly for 24 weeks

OTHER

Resistance training

Resistance training 3 times a week for 24 weeks

Trial Locations (2)

Institute of Sports Medicine, Bispebjerg Hospital, Bispebjerg

Department of Endocrinology, Odense University Hospital, Odense

All Listed Sponsors

collaborator

Bispebjerg Hospital

OTHER

lead

Odense University Hospital

OTHER

NCT07191353 - Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women | Biotech Hunter | Biotech Hunter